SurpassMD Review 2026: GLP-1 Pricing, Process & How It Compares
Sponsored review. SurpassMD is an advertising partner of Peptide Dossier. The pricing and program facts below are accurate as of July 2026 and we note the platform's limitations alongside its strengths.
SurpassMD is a GLP-1 telehealth platform offering compounded semaglutide from $134/month, compounded tirzepatide from $199/month, and oral semaglutide tablets, with licensed provider review and cold-chain shipping within 48 hours of approval. Launched under Life Vitality LLC, it competes at the low end of the compounded GLP-1 price range. This review covers how the program works, what it costs at each stage, and where competitors beat it.
What Is SurpassMD & How Does It Work?
SurpassMD is a digital health platform, not a medical practice or pharmacy. It connects patients with an independent licensed medical group whose clinicians review each intake, and with licensed 503A compounding pharmacies that dispense and ship medication when a prescription is issued. The platform operates in all 50 states plus Washington DC.
The process: complete an online assessment covering goals, health history, and current weight → an independent licensed provider reviews your information → if treatment is appropriate and a prescription is issued, medication ships cold-packed with tracking within 48 hours. There is no mandatory video visit for most patients, which keeps the process fast but also means less face time than consultation-heavy platforms.
SurpassMD is cash-pay only: no insurance, Medicare, or Medicaid billing. HSA/FSA cards and Klarna-style financing may be accepted at checkout.
SurpassMD Pricing: What $134/Month Actually Covers
The advertised prices — semaglutide from $134/month, tirzepatide from $199/month — are starting prices for eligible patients at entry doses, and include the provider review, medication, supplies, and shipping. Higher doses may cost more, which matters because most patients escalate toward a maintenance dose over 4-6 months. Before subscribing, ask what your expected maintenance dose will cost; that number, not the entry price, determines what you will actually spend over a year.
For context against the market as of July 2026: entry-level compounded semaglutide runs $179-299/month at TrimRx, Fridays, Henry Meds, and Remedy Meds, so SurpassMD's $134 floor is the lowest advertised entry price among the platforms we track. Fridays' 12-month prepaid plan ($150/month effective) is the closest committed-price competitor. See the full pricing landscape in our GLP-1 telehealth price comparison.
Medications: Semaglutide, Tirzepatide & an Oral Option
SurpassMD offers the two workhorse GLP-1 molecules. Compounded semaglutide (the active in Ozempic/Wegovy) is the value pick and produces roughly 15% body weight loss at 68 weeks in the STEP 1 trial of the brand-name drug. Compounded tirzepatide (the active in Mounjaro/Zepbound) is the stronger dual GLP-1/GIP agonist, with up to 22.5% weight loss in SURMOUNT-1. Oral semaglutide tablets are available for needle-averse patients, though oral bioavailability is far lower and daily dosing compensates.
Important: compounded versions of both drugs are prepared by state-licensed pharmacies but are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. For the regulatory background, see our guide to whether compounded semaglutide is legal in 2026.
Pros & Cons of SurpassMD
Pros
- Lowest advertised entry price we track: semaglutide from $134/mo
- 48-hour cold shipping beats the industry's 3-7 day norm
- All 50 states + DC coverage
- Oral semaglutide option for needle-averse patients
- HSA/FSA and buy-now-pay-later accepted; cancel anytime
- No membership fee separate from medication
Cons
- New brand (2026) with a limited public track record and few third-party reviews
- No insurance billing; not available to Medicare/Medicaid beneficiaries
- No structured nutrition coaching like Fridays offers
- Starting price rises with dose; maintenance-dose cost requires checkout to confirm
- Compounded medications are not FDA-approved
- Testosterone and peptide therapies not yet available
How SurpassMD Compares to Other GLP-1 Platforms
SurpassMD competes on entry price and shipping speed. TrimRx counters with flat pricing at every dose level ($349/month tirzepatide from starting dose to max), which can beat SurpassMD for patients heading to high maintenance doses. Fridays counters with coaching depth and a $150/month 12-month prepaid semaglutide rate. Henry Meds offers oral tirzepatide tablets that SurpassMD lacks. Remedy Meds offers simple month-to-month billing but at the highest prices in the cohort.
Head-to-head breakdowns: SurpassMD vs Henry Meds, SurpassMD vs TrimRx, SurpassMD vs Fridays, and SurpassMD vs Remedy Meds. For the full field, see the best GLP-1 telehealth providers roundup.
Who Should (and Shouldn't) Use SurpassMD
SurpassMD fits price-sensitive, self-directed patients who want compounded semaglutide or tirzepatide at the lowest advertised entry cost, fast fulfillment, and a minimal-friction online process. It is a weaker fit if you want intensive coaching (choose Fridays), guaranteed flat pricing at high doses (TrimRx), oral tirzepatide (Henry Meds), insurance-covered brand-name medication (Fridays, or your own physician), or an established brand with years of public reviews.
If you are comparing your first GLP-1, start with semaglutide vs tirzepatide to pick the molecule before you pick the platform.
Frequently Asked Questions
As of July 2026, SurpassMD advertises compounded semaglutide from $134/month and compounded tirzepatide from $199/month for eligible patients. Oral semaglutide tablets are also available. Actual pricing depends on the medication and dose a licensed provider prescribes, and higher doses may cost more. The subscription includes provider review and cold shipping, with no separate membership fee.
SurpassMD is a brand of Life Vitality LLC, a digital health platform that connects patients with an independent licensed medical group and licensed 503A compounding pharmacies. It operates in all 50 states plus DC. Like all compounded GLP-1 platforms, it is not itself a medical practice or pharmacy, prescriptions are never guaranteed, and the compounded medications it facilitates are not FDA-approved. It is a new brand as of 2026, which means a limited public track record compared to platforms like Henry Meds.
SurpassMD advertises cold-chain shipping within 48 hours of provider approval, with tracking. This is faster than the 3-7 business day fulfillment windows most competing GLP-1 telehealth platforms quote. Injectable compounded semaglutide and tirzepatide are temperature-sensitive and ship with ice packs.
No. SurpassMD is a cash-pay platform and does not bill insurance, Medicare, or Medicaid — it is also not available to Medicare or Medicaid beneficiaries. HSA/FSA cards may be accepted, and Klarna-style buy-now-pay-later options may be available at checkout. If you want help getting brand-name medication covered by insurance, a platform like Fridays is a better fit.
Three GLP-1 options for weight loss: compounded injectable semaglutide (from $134/month), compounded injectable tirzepatide (from $199/month), and oral semaglutide tablets for patients who prefer to avoid injections. A licensed provider determines which, if any, is appropriate. Testosterone and peptide therapies are not yet available on the platform.
No. You complete an online health intake, and an independent licensed provider reviews your health history, weight profile, medications, and contraindications before deciding whether treatment is appropriate. Not every applicant qualifies. Standard GLP-1 exclusions apply, including pregnancy, breastfeeding, personal or family history of medullary thyroid carcinoma or MEN2, and history of pancreatitis.
SurpassMD subscriptions are advertised as cancel-anytime. As with any GLP-1 telehealth subscription, cancel before your next billing cycle to avoid being charged for another month, and confirm the cancellation by email. If you are considering stopping GLP-1 treatment entirely rather than switching providers, read our guide to GLP-1 tapering first.
On advertised entry pricing, SurpassMD ($134/month semaglutide) undercuts TrimRx ($179 first month), Fridays ($249 rolling), Henry Meds ($297), and Remedy Meds ($299) as of July 2026. Fridays offers a cheaper 12-month prepaid rate ($150/month) and stronger coaching. TrimRx offers flat pricing through dose escalation. Henry Meds specializes in oral tirzepatide. SurpassMD competes on entry price and 48-hour shipping rather than coaching depth.
Sponsored content: SurpassMD is an advertising partner of Peptide Dossier. This page is informational and is not medical advice. Compounded medications are not FDA-approved or reviewed for safety, effectiveness, or quality. Prescriptions are never guaranteed; eligibility is determined by an independent licensed provider. Pricing verified July 2026 and subject to change.